Some properties of myeloid bodies induced in rat liver by an antidepressant drug (maprotiline).
D000135:Acid Phosphatase / Q000378:metabolism; D000818:Animals; D000873:Anthracenes / Q000494:pharmacology*; D002458:Cell Fractionation; D004305:Dose-Response Relationship, Drug; D006867:Hydrolases / Q000378:metabolism; D002479:Inclusion Bodies / Q000378:metabolism* / Q000648:ultrastructure; D008099:Liver / Q000187:drug effects* / Q000201:enzymology / Q000648:ultrastructure; D008247:Lysosomes / Q000201:enzymology; D008297:Male; D008376:Maprotiline / Q000494:pharmacology*; D008862:Microsomes, Liver / Q000201:enzymology; D008930:Mitochondria, Liver / Q000201:enzymology; D009996:Osmotic Fragility; D010743:Phospholipids / Q000378:metabolism; D051381:Rats
D000873:Anthracenes; D010743:Phospholipids; D008376:Maprotiline; D006867:Hydrolases; D000135:Acid Phosphatase